As we've highlighted, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical…
CFIF on Twitter CFIF on YouTube
Image of the Day: Private Sector Pharmaceutical Investment Propels Innovation

As we've highlighted, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical innovators often minimizes the role of private investment and exaggerates the role of public funding.  This offers a critical corrective at a moment when American drug and vaccine innovation is more important than ever:

[caption id="" align="aligncenter" width="530"] The Critical Role of Private Pharmaceutical Investment[/caption]…[more]

May 14, 2021 • 09:16 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Home Jester's Courtroom Brand Name Drug Makers Held Liable for Generic Drug Label Warnings
Brand Name Drug Makers Held Liable for Generic Drug Label Warnings Print
Thursday, September 04 2014

The Alabama Supreme Court recently upheld an earlier decision that found the makers of brand-name drugs liable for the warning labels on the generic version of their drugs.

Citing the theory of innovator liability, the Alabama Supreme Court ruled that, even if the plaintiff only used the generic brand, the brand-name drug maker had potential liability since generic drug makers must provide an exact copy of the warning labels on the brand-name drugs they copy. 

Alabama is the first state to find brand-name drug manufacturers potentially liable.

In 2011, the U.S. Supreme Court decided in Pliva v. Mensing that generic drug makers cannot be held liable through “failure to warn” lawsuits, since such claims are pre-empted by federal requirements that prevent the manufacturers from providing different warnings than are provided on the brand-name version.

According to news reports, the FDA is in the process of finalizing new generic drug label requirements.

Source: aboutlawsuits.com

Quiz Question   
What was the last year in which gold was used as the basis for valuing the U.S. dollar?
More Questions
Notable Quote   
 
"My colleague Casey Mulligan of the University of Chicago and I predicted in the Wall Street Journal three months ago that the $300 per week extra unemployment benefits would mean 5 to 6 million people not going back to work because the government was paying them more not to work. The Left laughed at this prediction. Now, we see record jobs going unfilled, 8.1 million, even when there are 9 million…[more]
 
 
—Stephen Moore, Co-Founder of the Committee to Unleash Prosperity and Former Member of President Trump’s Economic Recovery Task Force
— Stephen Moore, Co-Founder of the Committee to Unleash Prosperity and Former Member of President Trump’s Economic Recovery Task Force
 
Liberty Poll   

Which one of the following do you view as the greatest threat to the U.S. economy as we recover from the coronavirus disruption?